JP2023522030A5 - - Google Patents
Info
- Publication number
- JP2023522030A5 JP2023522030A5 JP2022562646A JP2022562646A JP2023522030A5 JP 2023522030 A5 JP2023522030 A5 JP 2023522030A5 JP 2022562646 A JP2022562646 A JP 2022562646A JP 2022562646 A JP2022562646 A JP 2022562646A JP 2023522030 A5 JP2023522030 A5 JP 2023522030A5
- Authority
- JP
- Japan
- Prior art keywords
- igg
- modified
- constant domain
- feline
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063011491P | 2020-04-17 | 2020-04-17 | |
| US63/011,491 | 2020-04-17 | ||
| PCT/US2021/027839 WO2021212084A1 (en) | 2020-04-17 | 2021-04-16 | Feline antibody variants |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023522030A JP2023522030A (ja) | 2023-05-26 |
| JP2023522030A5 true JP2023522030A5 (cg-RX-API-DMAC10.html) | 2024-04-22 |
Family
ID=75870744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022562646A Pending JP2023522030A (ja) | 2020-04-17 | 2021-04-16 | ネコ科動物抗体バリアント |
Country Status (17)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018318440A1 (en) | 2017-08-15 | 2020-02-13 | Kindred Biosciences, Inc. | IgG Fc variants for veterinary use |
| CN120005022A (zh) | 2019-01-03 | 2025-05-16 | 因外泰克斯公司 | 用于增加治疗剂在犬中的半衰期的组合物及使用方法 |
| JP7832123B2 (ja) | 2020-05-11 | 2026-03-17 | インベテックス インコーポレイテッド | 治療薬のイヌにおける半減期を増加させるための組成物及びその使用方法 |
| EP4166574A4 (en) * | 2020-06-10 | 2025-01-15 | Bica Therapeutics Inc. | FUSION PROTEIN WITH ERYTHROPOIETIN POLYPEPTIDE |
| CN116096741B (zh) | 2020-07-10 | 2024-10-18 | 因外泰克斯公司 | 用于延长治疗剂在猫科动物中的半衰期的组合物和使用方法 |
| IL301414A (en) * | 2020-09-29 | 2023-05-01 | Zoetis Services Llc | Feline antibody variants |
| WO2025166165A1 (en) * | 2024-02-01 | 2025-08-07 | Zoetis Services, Llc | Compositions and methods for modifying antibody effector functions |
| WO2026136223A1 (en) * | 2024-12-19 | 2026-06-25 | Zoetis Services Llc | Compositions and methods for improving feline antibody functions |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5807715A (en) | 1984-08-27 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin |
| GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US6284471B1 (en) | 1991-03-18 | 2001-09-04 | New York University Medical Center | Anti-TNFa antibodies and assays employing anti-TNFa antibodies |
| US5698762A (en) | 1994-12-09 | 1997-12-16 | Dauerman; Leonard | Microwave-assisted pyrolysis of waste polyaromatic hydrocarbons |
| US20030031671A1 (en) | 2001-08-01 | 2003-02-13 | Sydney Welt | Methods of treating colon cancer utilizing tumor-specific antibodies |
| CA2577133A1 (en) | 2004-08-19 | 2006-03-23 | Genentech, Inc. | Polypeptide variants with altered effector function |
| US9200079B2 (en) | 2004-11-12 | 2015-12-01 | Xencor, Inc. | Fc variants with altered binding to FcRn |
| US8367805B2 (en) | 2004-11-12 | 2013-02-05 | Xencor, Inc. | Fc variants with altered binding to FcRn |
| US8546543B2 (en) | 2004-11-12 | 2013-10-01 | Xencor, Inc. | Fc variants that extend antibody half-life |
| KR101616758B1 (ko) * | 2007-12-26 | 2016-04-29 | 젠코어 인코포레이티드 | FcRn에 대한 변경된 결합성을 갖는 Fc 변이체 |
| ES2665954T3 (es) | 2010-08-19 | 2018-04-30 | Zoetis Belgium S.A. | Anticuerpos anti-NGF y su uso |
| US8790651B2 (en) | 2011-07-21 | 2014-07-29 | Zoetis Llc | Interleukin-31 monoclonal antibody |
| US9617334B2 (en) | 2012-06-06 | 2017-04-11 | Zoetis Services Llc | Caninized anti-NGF antibodies and methods thereof |
| US10093731B2 (en) * | 2017-02-24 | 2018-10-09 | Kindred Biosciences, Inc. | Anti-IL31 antibodies for veterinary use |
| EP3866842A4 (en) * | 2018-10-18 | 2022-07-13 | Kindred Biosciences, Inc. | FC VARIANTS WITH MODIFIED BINDING TO THE NEONATAL FC RECEPTOR (FCRN) FOR VETERINARY USE |
| WO2020116560A1 (ja) * | 2018-12-05 | 2020-06-11 | 株式会社バイカ・セラピュティクス | 抗体のFc領域改変体 |
-
2021
- 2021-04-16 EP EP21724443.3A patent/EP4136109A1/en active Pending
- 2021-04-16 CN CN202180028968.3A patent/CN115667300A/zh active Pending
- 2021-04-16 US US17/918,860 patent/US20240067730A1/en active Pending
- 2021-04-16 PH PH1/2022/552743A patent/PH12022552743A1/en unknown
- 2021-04-16 WO PCT/US2021/027839 patent/WO2021212084A1/en not_active Ceased
- 2021-04-16 KR KR1020227035858A patent/KR20230005158A/ko active Pending
- 2021-04-16 MX MX2022012793A patent/MX2022012793A/es unknown
- 2021-04-16 CA CA3176434A patent/CA3176434A1/en active Pending
- 2021-04-16 AU AU2021257355A patent/AU2021257355A1/en active Pending
- 2021-04-16 PE PE2022002416A patent/PE20230348A1/es unknown
- 2021-04-16 JP JP2022562646A patent/JP2023522030A/ja active Pending
- 2021-04-16 IL IL297290A patent/IL297290A/en unknown
- 2021-04-16 BR BR112022020631A patent/BR112022020631A2/pt unknown
- 2021-04-19 TW TW110113948A patent/TW202204404A/zh unknown
-
2022
- 2022-10-17 EC ECSENADI202280858A patent/ECSP22080858A/es unknown
- 2022-10-17 CL CL2022002856A patent/CL2022002856A1/es unknown
- 2022-10-18 CO CONC2022/0014684A patent/CO2022014684A2/es unknown
-
2023
- 2023-11-13 CL CL2023003376A patent/CL2023003376A1/es unknown
-
2024
- 2024-04-19 US US18/640,470 patent/US20250026834A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023522029A5 (cg-RX-API-DMAC10.html) | ||
| JP7181612B2 (ja) | アルカリ安定性免疫グロブリン結合タンパク質 | |
| JP5812303B2 (ja) | 酸性域での親和性が低下したプロテインa変異型タンパク質及び抗体捕捉剤 | |
| JP2020506898A5 (cg-RX-API-DMAC10.html) | ||
| CN110520445B (zh) | 抗pd-l1/抗pd-1天然抗体结构样异源二聚体形式双特异抗体及其制备 | |
| Sachs et al. | Antibodies to a distinct antigenic determinant of staphylococcal nuclease | |
| IL276286B2 (en) | FC variants with improved binding to FCRN and extended half-life | |
| JP2023542737A5 (cg-RX-API-DMAC10.html) | ||
| KR102247704B1 (ko) | 항 pd-1/항 her2 천연항체 구조 형태의 헤테로다이머 계의 이중특이성 항체 및 그 제조방법 | |
| US20100168395A1 (en) | Novel polypeptide, an affinity chromatography material, and a method for separating and/or purifying immunoglobulin | |
| JP2023543262A5 (cg-RX-API-DMAC10.html) | ||
| WO2021120095A1 (zh) | 抗聚合酶的单克隆抗体及其应用 | |
| WO2022206900A1 (zh) | 抗人血清白蛋白(hsa)的纳米抗体及其应用 | |
| JPH10257893A5 (cg-RX-API-DMAC10.html) | ||
| PE20230348A1 (es) | Variantes de anticuerpos felinos | |
| EP3054009A1 (en) | PROTEIN COMPRISED BY LINKING BY LINKER MULTIPLE DOMAINS HAVING AFFINITY FOR PROTEINS HAVING Fc PART OF IMMUNOGLOBULIN G (IgG) | |
| JP2023551194A5 (cg-RX-API-DMAC10.html) | ||
| JP2024531346A5 (cg-RX-API-DMAC10.html) | ||
| EP4673442A1 (en) | Photoswitchable compounds and affinity ligands, and their use for the optical control of affinity matrices | |
| TW202026314A (zh) | 用於親和毛細管電泳之系統及方法 | |
| RU2023105687A (ru) | Варианты кошачьих антител | |
| JP2015003872A (ja) | マウスIgGの精製方法 | |
| JP2015019615A (ja) | プロテインgの細胞膜外ドメイン変異体の新規な改変型タンパク質 | |
| CN117700501A (zh) | 免疫球蛋白结合蛋白及其应用 | |
| JP2024522092A5 (cg-RX-API-DMAC10.html) |